Paper
0
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
Authors
Katie Ewer,Tommy Rampling
Navin Venkatraman,Georgina Bowyer,Daniel Wright,Teresa Lambe,Egeruan Imoukhuede,Ruth Payne,Sarah Fehling,Thomas Strecker,Nadine Biedenkopf,Verena Krähling,Claire Tully,Nick Edwards,Emma Bentley,Dhanraj Samuel,Geneviève Labbé,Jing Jin,Malick Gibani,Alice Minhinnick,Morven Wilkie,Ian Poulton,Natalie Lella,Rachel Roberts,Felicity Hartnell,Carly Bliss,Kailan Sierra-Davidson,Jonathan Powlson,Eleanor Berrie,Richard Tedder,François Roman,Iris Ryck,Alfredo Nicosia,Nancy Sullivan,Daphne Stanley,Olivier Mbaya,Julie Ledgerwood,Richard Schwartz,Loredana Siani,Stefano Colloca,Antonella Folgori,Stefania Marco,Riccardo Cortese,Edward Wright,Stephan Becker,Barney Graham,Richard Koup,Myron Levine,Ariane Volkmann,Paul Chaplin,Andrew Pollard,Simon Draper,W. Ballou,Alison Lawrie,Sarah Gilbert,Adrian Hill
+54 authors
,D. WrightPublished
Jan 28, 2015
Show more
Save
Tip0
TipSave
Abstract
The West African outbreak of Ebola virus disease that peaked in 2014 has caused more than 11,000 deaths. The development of an effective Ebola vaccine is a priority for control of a future outbreak.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.